BioWorld - Tuesday, December 23, 2025
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
» New NLRP3 inhibitors disclosed in Neushen Therapeutics patent
New NLRP3 inhibitors disclosed in Neushen Therapeutics patent
Neushen Therapeutics Inc. has divulged NLRP3 inhibitors reported to be useful for the treatment of neurodegeneration.
HIV research is close to a cure but far from ending the pandemic
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...